<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">SEVELAMER HYDROCHLORIDE <img border="0" src="../images/pr.gif"/></span><br/>(se-vel'a-mer)<br/><span class="topboxtradename">Renagel<br/></span><b>Classifications:</b> <span class="classification">electrolyte and water balance agent</span>; <span class="classification">phosphate binder</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>403 mg capsules; 400 mg, 800 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Polymer that binds intestinal phosphate; interacts with phosphate by way of ion-exchange and hydrogen binding. Advantageously,
         does not contain aluminum or calcium acetate in treating hyperphosphatemia in end stage kidney failure.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Indicated by a serum phosphate level <img src="../images/special/lesserorequal.gif"/>6.0 mg/dL.</p>
<h1><a name="uses">Uses</a></h1>
<p>Reduction of serum phosphorus in patients with end-stage kidney disease.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypophosphatemia; hypersensitivity to sevelamer HCl; bowel obstruction; pregnancy (category C), lactation. Safety and efficacy
         in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>GI motility disorders, dysphagia, GI surgery patients; vitamin deficiencies (especially vitamins D, E, K and folic acid).</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Hyperphosphatemia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2 capsules or tablets t.i.d. for serum phosphorus &gt;6 and 7.5
               and 9 mg/dL<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with meals; do not open or chew capsule.</li>
<li>Give other oral medications 1 h before or 3 h after Renagel.</li>
<li>Discard capsules after printed expiration date.</li>
<li>Store at 15°30° C (59°86° F); protect from moisture.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Headache, infection, pain. <span class="typehead">CV:</span> Hypertension, hypotension, thrombosis. <span class="typehead">GI:</span> Diarrhea, dyspepsia, vomiting, nausea, constipation, flatulence. <span class="typehead">Respiratory:</span> Increased cough. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Obtain frequent serum phosphate levels.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not use capsules after printed expiration date.</li>
<li>Take daily multivitamin supplement approved by physician.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>